{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:37:29Z","timestamp":1774384649588,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13555-026-01678-1","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:27:07Z","timestamp":1773336427000},"page":"1439-1443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Podcast: Adherence to Injectables"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-783X","authenticated-orcid":false,"given":"Jorge","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"9","key":"1678_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/17474124.2021.1898944","volume":"15","author":"D Denesh","year":"2021","unstructured":"Denesh D, Carbonell J, Kane JS, Gracie D, Selinger C. Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration. Expert Rev Gastroenterol Hepatol. 2021;15(9):1091\u20136.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"1678_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/10717544.2019.1587043","volume":"26","author":"BJF van den Bemt","year":"2019","unstructured":"van den Bemt BJF, Gettings L, Doma\u0144ska B, Bruggraber R, Mountian I, Kristen LE. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv. 2019;26(1):384\u201392.","journal-title":"Drug Deliv"},{"key":"1678_CR3","unstructured":"NICE guidelines. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. 2009. https:\/\/www.nice.org.uk\/guidance\/cg76\/chapter\/Introduction. Accessed September 2025"},{"key":"1678_CR4","unstructured":"WHO. Adherence to long-term therapies. 2003. https:\/\/iris.who.int\/bitstream\/handle\/10665\/42682\/9241545992.pdf?sequence=1&isAllowed=y. Accessed September 2025"},{"issue":"3","key":"1678_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/rheumatology\/keu358","volume":"54","author":"J Bluett","year":"2015","unstructured":"Bluett J, Morgan C, Thurston L, et\u00a0al. Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology (Oxford). 2015;54(3):494\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1678_CR6","first-page":"559","volume":"33","author":"R Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez R, Le\u00f3n L, Loza E, Redondo M, de Garc\u00eda Y\u00e9benes MJ, Carmona L. Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. Clin Exp Rheumatol. 2015;33(4):559\u201369.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1678_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40744-017-0080-4","volume":"4","author":"M Schiff","year":"2017","unstructured":"Schiff M, Saunderson S, Mountian I, Hartley P. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017;4(2):445\u201363.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"1678_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1517\/14712590903530633","volume":"10","author":"J Borr\u00e1s-Blasco","year":"2010","unstructured":"Borr\u00e1s-Blasco J, Gracia-P\u00e9rez A, Rosique-Robles JD, Caster\u00e1 MDE, Abad FJ. Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen. Expert Opin Biol Ther. 2010;10(3):301\u20137.","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"1678_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1517\/14712598.2013.795942","volume":"13","author":"J Borr\u00e1s-Blasco","year":"2013","unstructured":"Borr\u00e1s-Blasco J, Gracia-P\u00e9rez A, Caster\u00e1 MDE, Rosique-Robles JD, Abad J. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen. Expert Opin Biol Ther. 2013;13(8):1103\u20138.","journal-title":"Expert Opin Biol Ther"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01678-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:06:15Z","timestamp":1774371975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01678-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01678-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Professor S\u00e1nchez has been an advisor and speaker for Novartis AG; Sanofi SA; Glaxon; AstraZeneca PLC; Becton Dickinson and Company; Foundation for Advanced Education in the Sciences, Inc; Galderma SA; Nettle Pharma; and Thermo Fisher Scientific Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}